medigraphic.com
ISSN 2218-6719 (Print)

2016, Number 1

<< Back Next >>

Rev Cub de Tec de la Sal 2016; 7 (1)

Some current aspects about the handling of Alzheimer disease by Nursery professionals

Cruz GEF

Language: Spanish
References: 10
Page: 44-56
PDF size: 725.79 Kb.


ABSTRACT

Alzheimer disease is a degenerated and progressive brain disorder characterized by the disorientation, loss of memory and concentration. It is considered the primary cause of dementia in the oldness stage. The objective of this research work is to reinforce some aspects in the handling and decision-making of Nursery professionals who are in charge of taking care of sick people with Alzheimer.
It was analyzed different national and international authors whose research works deal with the object of study of this paper. The systematization carried out made clear the importance of reasonable consumption of caffeine, which can protect the brain from the loss of memory during the aging normal process, apart from other factors such as: diet and exercises. This way, these patient's memory would be evaluated. It was also proved that nursery professionals can carry out actions through the Nursery Attention Process in order to assess the patient's capacity to make decisions.


REFERENCES

  1. 1-Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer's disease: a randomized controlled trial. JAMA. 2008;300:1774-1783.

  2. 2-DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300:2253-2262.

  3. 3-Burns A, Iliffe S. Alzheimer's disease. BMJ. 2009;338:b158.doi:10.1136.bmj.b158.

  4. 4-Rapp MA, Reischies FM (2005). «Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE)» American Journal of Geriatric Psychiatry. Vol. 13. n.º 2. pp. 134–141

  5. 5 Twamley EW, Ropacki SA, Bondi«Neuropsychological and neuroimaging changes in preclinical Alzheimer's MW (September de 2006). disease» J IntNeuropsychol Soc. Vol. 12. n.º 5. pp. 707–35.

  6. 6 -Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L (2007). «Predictors of progression from mild cognitive impairment to Alzheimer disease» Neurology. Vol. 68. n.º 19. pp. 1596–1602.

  7. 8-De la Vega, R. y Zambrano, A. Alzheimer. La Circunvalación del hipocampo, mayo 2008.

  8. 9 -Boothby LA, Doering PL (2005). «Vitamin C and vitamin E for Alzheimer's disease» Ann Pharmacother. Vol. 39. n.º 12. pp. 2073–80.

  9. 10-Petersen RC (February de 2007). «The current status of mild cognitive impairment--what do we tell our patients?» Nat ClinPract Neurol. Vol. 3. n.º 2. pp. 60–1.

  10. 11.-Cirión Martinez Gladys.Herrera Pérez Miguel A. Anatomía Patológica. Temas para Enfermería. Editorial ECIMED 2005, Ciudad de la Habana.




2020     |     www.medigraphic.com